| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Colony stimulating factor (substance) |
Is a |
False |
Biological agent |
Inferred relationship |
Some |
|
| Synthetic copolymer |
Is a |
False |
Biological agent |
Inferred relationship |
Some |
|
| Monoclonal antibody agent |
Is a |
False |
Biological agent |
Inferred relationship |
Some |
|
| Product containing infliximab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biological agent |
Inferred relationship |
Some |
|
| Product containing palivizumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biological agent |
Inferred relationship |
Some |
|
| Product containing monoclonal antibody (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biological agent |
Inferred relationship |
Some |
|
| Product containing rituximab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biological agent |
Inferred relationship |
Some |
|
| Product containing etanercept (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biological agent |
Inferred relationship |
Some |
|
| Palivizumab 50mg powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biological agent |
Inferred relationship |
Some |
|
| Interleukins |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biological agent |
Inferred relationship |
Some |
|
| Rituximab 10mg/mL injection concentrate 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biological agent |
Inferred relationship |
Some |
|
| Rituximab 10mg/mL infusion concentrate 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biological agent |
Inferred relationship |
Some |
|
| Product containing trastuzumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biological agent |
Inferred relationship |
Some |
|
| Trastuzumab 150 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biological agent |
Inferred relationship |
Some |
|
| Mouse monoclonal antibody |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biological agent |
Inferred relationship |
Some |
|
| Product containing murine-human monoclonal immunoglobulin G antibody |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biological agent |
Inferred relationship |
Some |
|
| Infliximab 100mg powder for infusion solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biological agent |
Inferred relationship |
Some |
|
| Etanercept 25mg powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biological agent |
Inferred relationship |
Some |
|
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biological agent |
Inferred relationship |
Some |
|
| Etanercept 25mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biological agent |
Inferred relationship |
Some |
|
| Trastuzumab 440 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biological agent |
Inferred relationship |
Some |
|
| Palivizumab 100mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biological agent |
Inferred relationship |
Some |
|
| Infliximab 100mg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biological agent |
Inferred relationship |
Some |
|
| Rituximab 500mg infusion concentrate vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biological agent |
Inferred relationship |
Some |
|
| Rituximab 100mg infusion concentrate vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biological agent |
Inferred relationship |
Some |
|
| Product containing gemtuzumab ozogamicin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biological agent |
Inferred relationship |
Some |
|
| Abciximab (substance) |
Is a |
False |
Biological agent |
Inferred relationship |
Some |
|
| Product containing alemtuzumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biological agent |
Inferred relationship |
Some |
|
| Alemtuzumab 30mg/3mL infusion concentrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biological agent |
Inferred relationship |
Some |
|
| Biological agent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biological agent |
Inferred relationship |
Some |
|